Skip to main content

Advertisement

SpringerLink
Log in

Cytoplasmic and nuclear expression of survivin in melanocytic skin lesions

  • Original Paper
  • Published:
Archives of Dermatological Research Aims and scope Submit manuscript

Abstract

Survivin, a member of the inhibitors of apoptosis protein family, regulates both cellular proliferation and apoptotic cell death. While the human survivin gene is highly expressed in the developing fetus, in adults its expression is restricted to highly proliferating normal tissues and neoplastic tumors tissues. In the present study, we compared the expression of survivin in melanoma and benign melanocytic lesions such as junctional, compound, dermal, congenital, blue and spitz nevi. This analysis reveals a heterogeneous expression of survivin with respect to both the intensity, frequency and cellular localization. In junctional, compound and blue nevi, survivin was present in nuclear localization, whereas in spitz nevi survivin was detectable in the cytoplasm. In dermal and congenital nevi, survivin was present in both localizations with predominance of the nuclear compartment. Interestingly, this distribution was similar to that observed in primary melanoma; whereas in metastatic melanoma the predominance of the nuclear localization of survivin was lost. Our data demonstrate that although survivin is expressed in a large number of benign nevi, the balance between its cytoplasmic and nuclear expression was immensely heterogeneous between lesions with suspected different developmental origins.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Kasof GM, Lu JJ, Liu D, Speer B, Mongan KN, Gomes BC, Lorenzi MV (2001) Tumor Necrosis Factor-Alpha Induces the Expression of DR6, a Member of the TNF Receptor Family, Through Activation of NF-KappaB. Oncogene 20(55):7965–7975

    Article  PubMed  CAS  Google Scholar 

  2. Ambrosini G, Adida C, Altieri DC (1997) A novel anti-apoptosis gene, Survivin, expressed in cancer and lymphoma. Nat Med 3(8):917–921

    Article  PubMed  CAS  Google Scholar 

  3. Koch CA, Vortmeyer AO, Diallo R, Poremba C, Giordano TJ, Sanders D, Bornstein SR, Chrousos GP, Pacak K (2002) Survivin: a novel neuroendocrine marker for pheochromocytoma. Eur J Endocrinol 146(3):381–388

    Article  PubMed  CAS  Google Scholar 

  4. Adida C, Haioun C, Gaulard P, Lepage E, Morel P, Briere J, Dombret H, Reyes F, Diebold J, Gisselbrecht C, Salles G, Altieri DC, Molina TJ (2000) Prognostic significance of survivin expression in diffuse large B-cell lymphomas. Blood 96(5):1921–1925

    PubMed  CAS  Google Scholar 

  5. Grossman D, McNiff JM, Li F, Altieri DC (1999) Expression and targeting of the apoptosis inhibitor, survivin, in human melanoma. J Invest Dermatol 113(6):1076–1081

    Article  PubMed  CAS  Google Scholar 

  6. Grossman D, McNiff JM, Li F, Altieri DC (1999) Expression of the apoptosis Inhibitor, Survivin, in Nonmelanoma Skin Cancer and Gene Targeting in a keratinocyte cell line. lab invest 79(9):1121–1126

    PubMed  CAS  Google Scholar 

  7. Bowen AR, Hanks AN, Allen SM, Alexander A, Diedrich MJ, Grossman D (2003) Apoptosis regulators and responses in human melanocytic and keratinocytic cells. J Invest Dermatol 120(1):48–55

    Article  PubMed  CAS  Google Scholar 

  8. Islam A, Kageyama H, Takada N, Kawamoto T, Takayasu H, Isogai E, Ohira M, Hashizume K, Kobayashi H, Kaneko Y, Nakagawara A (2000) High expression of survivin, mapped to 17q25, is significantly associated with poor prognostic factors and promotes cell survival in human neuroblastoma. oncogene 19(5):617–623

    Article  PubMed  CAS  Google Scholar 

  9. Swana HS, Grossman D, Anthony JN, Weiss RM, Altieri DC (1999) Tumor content of the antiapoptosis molecule survivin and recurrence of bladder cancer. N Engl J Med 341(6):452–453

    Article  PubMed  CAS  Google Scholar 

  10. Lee KH, Panelli MC, Kim CJ, Riker AI, Bettinotti MP, Roden MM, Fetsch P, Abati A, Rosenberg SA, Marincola FM (1998) Functional dissociation between local and systemic immune response during anti-melanoma peptide vaccination. J Immunol 161(8):4183–4194

    PubMed  CAS  Google Scholar 

  11. Ambrosini G, Adida C, Sirugo G, Altieri DC. Induction of apoptosis and inhibition of cell proliferation by survivin gene targeting

  12. Okada E, Murai Y, Matsui K, Isizawa S, Cheng C, Masuda M, Takano Y. Survivin expression in tumor cell nuclei is predictive of a favorable prognosis in gastric cancer patients

  13. Fensterle J, Becker JC, Potapenko T, Heimbach V, Vetter CS, Brocker EB, Rapp UR (2004) B-Raf specific antibody responses in melanoma patients. BMC Cancer 4(1):62

    Article  PubMed  CAS  Google Scholar 

  14. Satyamoorthy K, Bogenrieder T, Herlyn M (2001) No longer a molecular black box—new clues to apoptosis and drug resistance in melanoma. Trends Mol Med 7(5):191–194

    Article  PubMed  CAS  Google Scholar 

  15. Thomas WD, Hersey P (1998) TNF-related apoptosis-inducing ligand (TRAIL) induces apoptosis in Fas ligand-resistant melanoma cells and mediates CD4 T cell killing of target cells. J Immunol 161(5):2195–2200

    PubMed  CAS  Google Scholar 

  16. Tang L, Tron VA, Reed JC, Mah KJ, Krajewska M, Li G, Zhou X, Ho VC, Trotter MJ (1998) Expression of apoptosis regulators in cutaneous malignant melanoma. Clin Cancer Res 4(8):1865–1871

    PubMed  CAS  Google Scholar 

  17. Soengas MS, Capodieci P, Polsky D, Mora J, Esteller M, Opitz-Araya X, McCombie R, Herman JG, Gerald WL, Lazebnik YA, Cordon-Cardo C, Lowe SW (2001) Inactivation of the apoptosis effector Apaf-1 in malignant melanoma. Nature 409(6817):207–211

    Article  PubMed  CAS  Google Scholar 

  18. Vucic D, Stennicke HR, Pisabarro MT, Salvesen GS, Dixit VM (2000) ML-IAP, a novel inhibitor of apoptosis that is preferentially expressed in human melanomas. Curr Biol 10(21):1359–1366

    Article  PubMed  CAS  Google Scholar 

  19. Williams GT (1991) Programmed cell death: apoptosis and oncogenesis. Cell 65(7):1097–1098

    Article  PubMed  CAS  Google Scholar 

  20. Raff MC (1992) Social controls on cell survival and cell death. Nature 356(6368):397–400

    Article  PubMed  CAS  Google Scholar 

  21. Williams GT, Smith CA (1993) Molecular regulation of apoptosis: genetic controls on cell death. Cell 74(5):777–779

    Article  PubMed  CAS  Google Scholar 

  22. Gilchrest BA, Eller MS, Geller AC, Yaar M (1999) The pathogenesis of melanoma induced by ultraviolet radiation. N Engl J Med 340(17):1341–1348

    Article  PubMed  CAS  Google Scholar 

  23. Alanko T, Rosenberg M, Saksela O (1999) FGF expression allows nevus cells to survive in three-dimensional collagen gel under conditions that induce apoptosis in normal human melanocytes. J Invest Dermatol 113(1):111–116

    Article  PubMed  CAS  Google Scholar 

  24. Li G, Tang L, Zhou X, Tron V, Ho V (1998) Chemotherapy-induced apoptosis in melanoma cells is P53 dependent. melanoma Res 8(1):17–23

    Article  PubMed  CAS  Google Scholar 

  25. Mooney EE, Ruis Peris JM, O’Neill A, Sweeney EC (1995) Apoptotic and mitotic indices in malignant melanoma and basal cell carcinoma. J Clin Pathol 48(3):242–244

    Article  PubMed  CAS  Google Scholar 

  26. Bastian BC (2003) Understanding the progression of melanocytic neoplasia using genomic analysis: from fields to cancer. Oncogene 22(20):3081–3086

    Article  PubMed  CAS  Google Scholar 

  27. Frost M, Jarboe EA, Orlicky D, Gianani R, Thompson LC, Enomoto T, Shroyer KR (2002) Immunohistochemical localization of survivin in benign cervical mucosa, cervical dysplasia, and invasive squamous cell carcinoma. Am J Clin Pathol 117(5):738–744

    Article  PubMed  Google Scholar 

  28. Herlyn M, Berking C, Li G, Satyamoorthy K (2000) Lessons from melanocyte development for understanding the biological events in naevus and melanoma formation. melanoma Res 10(4):303–312

    Article  PubMed  CAS  Google Scholar 

  29. Ito T, Shiraki K, Sugimoto K, Yamanaka T, Fujikawa K, Ito M, Takase K, Moriyama M, Kawano H, Hayashida M, Nakano T, Suzuki A (2000) Survivin promotes cell proliferation in human hepatocellular carcinoma. hepatology 31(5):1080–1085

    Article  PubMed  CAS  Google Scholar 

  30. Yoshida H, Ishiko O, Sumi T, Matsumoto Y, Ogita S (2001) Survivin, Bcl-2 and matrix metalloproteinase-2 enhance progression of clear cell- and serous-type ovarian carcinomas. Int J Oncol 19(3):537–542

    PubMed  CAS  Google Scholar 

  31. Grabowski P, Kuhnel T, Muhr-Wilkenshoff F, Heine B, Stein H, Hopfner M, Germer CT, Scherubl H (2003) Prognostic value of nuclear survivin expression in oesophageal squamous cell carcinoma. Br J Cancer 88(1):115–119

    Article  PubMed  CAS  Google Scholar 

  32. Marusawa H, Matsuzawa S, Welsh K, Zou H, Armstrong R, Tamm I, Reed JC (2003) HBXIP functions as a cofactor of survivin in apoptosis suppression. EMBO J22(11):2729–2740

    Article  PubMed  CAS  Google Scholar 

  33. Meier F, Satyamoorthy K, Nesbit M, Hsu MY, Schittek B, Garbe C, Herlyn M (1998) Molecular events in melanoma development and progression. front biosci 3:D1005–D1010

    PubMed  CAS  Google Scholar 

  34. Li G, Herlyn M (2000) Dynamics of intercellular communication during melanoma development. Mol Med Today 6(4):163–169

    Article  PubMed  CAS  Google Scholar 

  35. Morales-Ducret CR, van de Rijn M, Smoller BR (1995) Bcl-2 expression in melanocytic nevi. Insights into the biology of dermal maturation. Arch Dermatol 131(8):915–918

    Article  PubMed  CAS  Google Scholar 

  36. Sprecher E, Bergman R, Meilick A, Kerner H, Manov L, Reiter I, Shafer Y, Maor G, Friedman-Birnbaum R (1999) Apoptosis, Fas and Fas-ligand expression in melanocytic tumors. J Cutan Pathol 26(2):72–77

    Article  PubMed  CAS  Google Scholar 

  37. Boni R, Wellmann A, Man YG, Hofbauer G, Brinkmann U (1999) Expression of the proliferation and apoptosis-associated CAS protein in benign and malignant cutaneous melanocytic lesions. Am J Dermatopathol 21(2):125–128

    Article  PubMed  CAS  Google Scholar 

  38. Shennan MG, Badin AC, Walsh S, Summers A, From L, McKenzie M, Goldstein AM, Tucker MA, Hogg D, Lassam N (2000) Lack of germline CDK6 mutations in familial melanoma. Oncogene 19(14):1849–1852

    Article  PubMed  CAS  Google Scholar 

  39. Badie C, Itzhaki JE, Sullivan MJ, Carpenter AJ, Porter AC (2000) Repression of CDK1 and other genes with CDE and CHR promoter elements during DNA damage-induced G(2)/M arrest in human cells. Mol Cell Biol 20(7):2358–2366

    Article  PubMed  CAS  Google Scholar 

  40. Zhao J, Tenev T, Martins LM, Downward J, Lemoine NR (2000) The Ubiquitin-proteasome pathway regulates survivin degradation in a cell cycle-dependent manner. J Cell Sci 113(Pt23):4363–4371

    PubMed  CAS  Google Scholar 

  41. O’Connor DS, Wall NR, Porter AC, Altieri DCA (2002) P34(Cdc2) survival checkpoint in cancer. Cancer Cell 2(1):43–54

    Article  PubMed  CAS  Google Scholar 

  42. Fukuda S, Foster RG, Porter SB, Pelus LM (2002) The antiapoptosis protein survivin is associated with cell cycle entry of normal cord blood CD34(+) cells and modulates cell cycle and proliferation of mouse hematopoietic progenitor cells. Blood 100(7):2463–2471

    Article  PubMed  CAS  Google Scholar 

  43. Shen Y, Devgan G, Darnell JE Jr, Bromberg JF (2001) Constitutively activated stat3 protects fibroblasts from serum withdrawal and UV-induced apoptosis and antagonizes the proapoptotic effects of Activated Stat1. Proc Natl Acad Sci U S A 98(4):1543–1548

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology, University of Würzburg, Josef-Schneider-Str. 2, 97080, Wuerzburg, Germany

    Claudia S. Vetter, Katrin Müller-Blech, David Schrama, Eva-B. Bröcker & Jürgen C. Becker

Authors
  1. Claudia S. Vetter
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Katrin Müller-Blech
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. David Schrama
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Eva-B. Bröcker
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jürgen C. Becker
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jürgen C. Becker.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Vetter, C.S., Müller-Blech, K., Schrama, D. et al. Cytoplasmic and nuclear expression of survivin in melanocytic skin lesions. Arch Dermatol Res 297, 26–30 (2005). https://doi.org/10.1007/s00403-005-0572-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00403-005-0572-x

Keywords

Search

Navigation